Cannabix Technologies Comments on Bill C-46 – Unaware of Any Material Change

UF startup Cannabix Technologies Inc., the developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, provides the following statement related to the government of Canada’s authorization of roadside saliva-testing devices under bill C-46: “It has been well signaled for some time by the Canadian government that a roadside saliva-testing device would be […]

Sun Biopharma, Inc. Presents Poster at Pancreasfest in Pittsburgh, Pa. (Globe Newswire)

UF startup Sun BioPharma, Inc., a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic diseases, announced the presentation of a poster reviewing the results of the Phase 1 Safety Study of its candidate drug, SBP-101, a polyamine metabolic inhibitor for pancreatic ductal adenocarcinoma (PDA) at PancreasFest in Pittsburgh, PA. […]

New Diagnostic Blood Test Developed for Concussions (eHealth News)

UF biotech company, Banyan Biomarkers, Inc. has developed the first blood test that can be used by physicians to objectively aid in the evaluation of patients with suspected traumatic brain injury (TBI) or concussions. Banyan is a University of Florida startup and a graduate of UF Innovate | Sid Martin Biotech. The Banyan Brain Trauma Indicator® […]

Ology Bioservices and RAFA Laboratories Announce FDA Approval of the Atropine Autoinjector as a Medi (BioFlorida)

UF startup and Sid Martin Biotech alum Ology Bioservices, Inc., a biologics contract development and manufacturing organization, and Rafa Laboratories, Ltd., a leading Israeli pharmaceutical company, announced that on July 9, 2018, they received full approval from the U.S. Food and Drug Administration (FDA) for the Atropine Injection, 2mg/0.7mL, Single-Dose Autoinjector. The Atropine Autoinjector initially […]

AxoGen, Inc Common Stock (AXGN) Sets New 1-Year High at $56.85 (Fairfield Current)

UF startup and Sid Martin Biotech alum AxoGen, Inc reported that its Common Stock (NASDAQ:AXGN) shares hit a new 52-week high during mid-day trading on Tuesday. The company traded as high as $56.85 and last traded at $54.90, with a volume of 4762 shares changing hands. The stock had previously closed at $56.60. The company […]

AGTC Treats First Patient of Second Cohort in Phase 1/2 Clinical XLRP Study; Earns $10 Million Enrollment Milestone (BioFlorida)

Applied Genetic Technologies Corporation, a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced that it has enrolled the first patient of the second cohort in the company’s Phase 1/2 clinical trial evaluating the safety and efficacy of an investigational AAV-based gene therapy for the […]

RTI Donor Services and the UMTB Donor Services Foundation Expand Partnership to Increase Capacity for Donated Tissue in Service to Patients, Donor Families and Leading Hospital Partners (Business Wire)

RTI Donor Services, Inc., a nonprofit organization dedicated to providing responsible stewardship of the gift of tissue donation, announced a new partnership with the UMTB Donor Services Foundation, a not-for-profit tissue recovery program based in Miami. The partnership aims to treat more patients by providing increased support for families seeking to donate the Gift of […]

UF Startup Receives $50K Award From Innovation Fund America

Innovation Fund Northeast Ohio, the region’s most active pre-seed fund for technology-based startups, has awarded a combined $737,500 to 14 startup companies over the past six months. The companies will receive Innovation Fund awards of between $12,500 and $100,000 enabling them to complete projects that will advance their technologies or business models.  UF startup Structured […]

Clinipace Drives Study Startup Optimization with goBalto (PR Newswire)

goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced that UF startup Clinipace has chosen goBalto’s end-to-end platform for starting clinical trials. If you fail to plan, you are planning to fail. These words ring true when it comes to study startup, a notorious bottleneck in clinical trials. With research showing a […]